PREVENAR 20

Suspension for injection in pre-filled syringe, 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 4.4mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml
RxActive license

Active substance (INN)

pneumococcal polysaccharide conjugate vaccine, adsorbed

Pharmaceutical form

Pharmaceutical formSuspension for injection in pre-filled syringe
Strength2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 4.4mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml + 2.2mcg/0.5ml
PackagingUkupno 1 napunjeni injekcioni špric sa 0.5ml suspenzije za injekciju (sa 1 iglom) u kartonskoj kutiji
ManufacturerPfizer Manufacturing Belgium NV, Belgium
Therapeutic groupAnti-infectives for systemic use (J07AL02)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateSeptember 20, 2024

Analogs in Montenegro

5

Other medicines with the same active substance

Source: CInMED register